Latest news, press releases, articles and announcements.

    • LAB282 is a £10m+ partnership, created to identify and develop new approaches to treating serious diseases. more
    • Enzbond launches to make fast, effective enzyme development a reality. more
    • Why the smart money is investing in University research (paywall). more
    • Argonaut to develop cancer therapies that reprogram tumours to die. more
    • Sleep and circadian rhythm disruption addressed by new Oxford spinout Circadian Therapeutics. more
    • Oxford most prolific university innovator in Europe. more
    • Oxford spinout Omass to provide native mass-spectrometry to pharma and biotech. more
    • Record £16.9m for Oxford spinout designing stem cell drugs to treat age-related disease. more
    • Universal Flu vaccine under development by Oxford spinout Vaccitech. more
    • EvOx Therapeutics raises £10m for precision system to treat disease. more
    • Oxford Nanoimaging to provide desktop super-resolution microscopes. more
    • Oxford machine learning spinout unlocks big data insights. more
    • Oxford spinout Zegami launches data discovery software to manage ‘information tsunami”. more
    • Oxford spinout Orbit Discovery launches peptide-discovery platform. more
    • Oxford Endovascular develop tiny mesh tubes to treat brain aneurysms. more
    • Bodle to use phase change materials for smart glazing and displays. more
    • New valve is Oxford Science Innovation’s first investment. more